One of the main benefits touted by Lilly is that Strattera is the only ADHD drug on the market that is not a stimulant, meaning users are less likely to abuse it. The makers of Adderall and Concerta ...

THE POWER of marketing can clearly be seen in the case of Strattera, Eli Lilly's new drug for attention deficit/hyperactivity disorder. The company is hoping its drug will help fill the gap left in ...

The Food and Drug Administration warned doctors Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit ...

Eli Lilly could be facing generic competition far sooner than expected for Strattera, after a US court ruled that a key patent on the attention deficit hyperactivity disorder treatment is invalid. Eli ...